Twin sisters Taylor Capuano and Casey Sarai started Cakes Body with just $10,000 in personal savings. Within three years, their simple solution for wardrobe malfunctions generated $95 million in net sales. Here’s what their explosive growth reveals about modern entrepreneurship.
T-Mobile customers are seeing mysterious uninstall notifications as AppHub gets removed. This marks a turning point in carrier bloatware practices and Android privacy standards.
Apple’s iOS 26.1 and iPadOS 26.1 address over 50 security vulnerabilities, including critical flaws in Stolen Device Protection and WebKit. The update represents Apple’s first major security patch since the initial iOS 26 release last September.
Bluesky’s new dislike feature aims to revolutionize content personalization, but history suggests user-driven moderation faces significant challenges. The platform’s approach could either create the most customized social experience or amplify echo chamber effects.
UPS’s latest 5.9% rate increase, mirroring FedEx’s move, signals deeper structural changes in shipping economics. The era of cheap delivery may be permanently over as carriers face rising operational costs and shifting consumer patterns.
Researchers have discovered specific bacteria that consistently appear alongside toxic algae blooms, potentially revolutionizing how we monitor water safety. This breakthrough could provide early warnings before dangerous cyanotoxins reach dangerous levels. The findings offer a more practical altern
Scientists have discovered a surprising pathway for creating complex carbon molecules in space. Radiation transforms common organic compounds into the building blocks of buckyballs, potentially explaining their abundance throughout the universe.
Researchers have cracked the code for mass-producing nature’s most sophisticated camouflage pigment. This breakthrough could revolutionize everything from military tech to sustainable cosmetics.
Corporate reputation isn’t just about avoiding scandals—it’s becoming a measurable financial asset. New research reveals why character reputation matters more than competence when crisis strikes, with profound implications for business strategy and valuation.
Stockholm-based BOOST Pharma has raised €3.1 million from Sound Bioventures to accelerate clinical development of BT-101, a pioneering stem cell therapy for children with brittle bone disease. The investment reflects Europe’s growing commitment to advanced cell therapies for rare pediatric condition
